Valuations for popular ETFs focused on US stocks are reaching extremes; investors should seek stocks with low risks and high ...

Last July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the ...

HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Thursday reported a loss of $3.6 million in its fourth quarter. On a per-share basis, the High Point ...

Tv Therapeutics (NASDAQ:VTVT) said on Monday that the U.S. FDA has lifted the clinical hold on cadisegliatin's clinical trial ...

Clinical hold lifted for late stage cadisegliatin program for diabetesCATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to ...

HIGH POINT, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first ...

We are thrilled our cadisegliatin clinical program can resume following the lifting of the clinical hold by the U.S. Food and Drug ...

vTv Therapeutics Inc. (NASDAQ:VTVT – Get Free Report) was the target of a significant decline in short interest in the month of February.As of February 28th, there was short interest totalling ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Thursday reported a loss of $3.6 million in its fourth quarter. On a per-share basis, the High Point, North ...